2026-01-26 - Analysis Report
**Company Overview**
Align Technology is a global medical device company that designs, manufactures, and markets a portfolio of products that improve patient outcomes and transform lives.

**Return Rate Comparison**

* Review Stock (ALGN): -15.84%
* S&P 500 (VOO): 126.41%
* Divergence: -140.30
* Relative Divergence: 5.20%

The review stock underperformed the S&P 500 by -142.25% points, resulting in a divergence of -140.30.

**Alpha, Beta Analysis**

| Year | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------|------|------|-------|------|-------|
| 2016-2018 | 65.0% | 48.7% | 53.0% | 1.5 | 15.2B |
| 2017-2019 | 79.0% | 51.1% | 54.0% | 1.6 | 20.2B |
| 2018-2020 | 81.0% | 56.9% | 57.0% | 1.5 | 38.7B |
| 2019-2021 | 166.0% | 53.3% | 100.0% | 1.5 | 47.6B |
| 2020-2022 | -70.0% | 73.3% | -77.0% | 1.5 | 15.3B |
| 2021-2023 | -195.0% | 73.3% | -216.0% | 1.7 | 19.9B |
| 2022-2024 | -169.0% | 65.1% | -198.0% | 1.7 | 15.1B |
| 2023-2025 | -62.0% | 60.0% | -137.0% | 1.5 | 11.3B |

The review stock performed well in the 2016-2020 period, with a high CAGR of 81.0%. However, it underperformed in the 2020-2025 period, with a negative CAGR.

**Recent Stock Price Fluctuations**

* Close: $168.73
* Last-market: -0.11%
* 5-day SMA: $168.93
* 20-day SMA: $165.49
* 60-day SMA: $153.17

The review stock price is trending below its 60-day SMA, indicating a potential bearish trend.

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence**

* MRI: 0.70 (Medium Investment)
* RSI: 67.72
* PPO: -0.33
* Hybrid Signal: Buy (Cash 0%)
* Recent relative divergence change: -0.10 (-)
* 7-day Rank change: 0 (0)
* 7-day Dynamic Expected Return change: 0.00 (0)
* Expected Return: -793.60%

The MRI indicates a medium-risk investment, and the RSI and PPO indicators suggest a potential sell signal.

**Recent News & Significant Events**

* [2026-01-22] Assessing Align Technology (ALGN) Valuation After Recent Share Price Momentum And Mixed Signals - Yahoo Finance
* [2026-01-24] Align Technology (ALGN) Valuation Check As Restructuring And New Product Suite Attract Fresh Investor Attention - simplywall.st
* [2026-01-20] New Analyst Forecast: $ALGN Given $200 Price Target - Quiver Quantitative
* [2026-01-19] Align Technology Q4 Preview: Even After A Big Drop In Price, Itâ€™s Too Expensive (ALGN) - Seeking Alpha
* [2026-01-22] Align Expands Invisalign To Thailand As Analysts Reassess ALGN Outlook - Sahm

**Analyst Opinions**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.17 (~Buy)
- Opinions: 15
- Target Price (avg/high/low): 183.87 / 220.00 / 150.00

The analyst consensus suggests a buy recommendation with a target price of $183.87.

**Recent Earnings Analysis**

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-11-05 | 0.78 | 1.00 B$ |
| 2025-08-06 | 1.72 | 1.01 B$ |
| 2025-05-08 | 1.27 | 0.98 B$ |
| 2024-11-05 | 1.55 | 0.98 B$ |
| 2025-11-05 | 1.55 | 0.98 B$ |

The review stock has reported declining EPS and revenue in recent quarters.

**Financial Information**

Revenue and Profitability:

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $1.00B | 64.20% |
| 2025-06-30 | $1.01B | 69.94% |
| 2025-03-31 | $0.98B | 69.45% |
| 2024-12-31 | $1.00B | 70.03% |
| 2024-09-30 | $0.98B | 69.72% |

Capital and Profitability:

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $3.96B | 1.43% |
| 2025-06-30 | $3.91B | 3.18% |
| 2025-03-31 | $3.79B | 2.46% |
| 2024-12-31 | $3.85B | 2.69% |
| 2024-09-30 | $3.94B | 2.94% |

The review stock has reported increasing revenue and profitability in recent quarters, but declining ROE.

**Comprehensive Analysis (Summary of previous items)**

The review stock has performed poorly in recent years, with a negative CAGR and declining EPS and revenue. The analyst consensus suggests a buy recommendation, but the RSI and PPO indicators suggest a potential sell signal. The stock price is trending below its 60-day SMA, indicating a potential bearish trend. The MRI indicates a medium-risk investment.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.